Sustituto de suero KnockOut™
Sustituto de suero KnockOut™
Gibco™

Sustituto de suero KnockOut™

El sustituto de suero KnockOut™ (KnockOut™ SR) se ha destinado al cultivo sin suero y se basa en alimentadores deMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
10828010100 mL
10828028500 mL
Número de catálogo 10828010
Precio (CLP)
124.753
Each
Añadir al carro de la compra
Cantidad:
100 mL
Precio (CLP)
124.753
Each
Añadir al carro de la compra
El sustituto de suero KnockOut™ (KnockOut™ SR) se ha destinado al cultivo sin suero y se basa en alimentadores de células madre embrionarias (ESC) y células madre pluripotentes inducidas (iPSC) de varias especies. Esta formulación definida, sin suero, reemplaza directamente al SFB en los protocolos existentes.

Muchos de los inconvenientes de usar SFB en el cultivo de células madre, (diferenciación de las células e inactivación por calor) se pueden mitigar con el sustituto de suero KnockOut™. Las células ES e iPS cultivadas en medios suplementados con KnockOut™ SR se diferencian sustancialmente menos que aquellas cultivadas en medios suplementados con SFB. Además, la transmisión germinal no debe verse comprometida. Con más de 2000 publicaciones revisadas por expertos que abarcan aplicaciones como el cultivo de células madre, la diferenciación, la generación de iPSC, la derivación ESC y el modelado transgénico, el sustituto de suero KnockOut™ se cita con frecuencia para cultivar células madre.
For research use only. Not for use in diagnostic procedures.
Especificaciones
Tipo de célulaCélulas madre (embrionarias)
ClasificaciónSin suero
Tipo de cultivoCultivo de células de mamífero
Para utilizar con (aplicación)Investigación clínica, investigación traslacional
Calidad de fabricacióncGMP para dispositivos médicos, 21 CFR parte 820 e ISO 13485
Línea de productosKnockOut
Grado de pureza o calidadVálido para células madre embrionarias (ES)
Nivel de sueroSin suero
Duración de almacenamiento18 meses
Condiciones de envíoHielo seco
EspecieSin suero
Probado paraEnsayo de rendimiento de crecimiento
FormularioCongelado
Tipo de productoSustitutivo del suero
Cantidad100 mL
pHentre 6 y 8
Unit SizeEach
Contenido y almacenamiento
Almacenar en el congelador (de -5 a -20°C) y proteger de la luz.

Preguntas frecuentes

Can KnockOut SR be used to culture mouse ESCs in feeder-free conditions?

Yes, mouse embryonic stem cells can be cultured using KnockOut SR under feeder-free conditions. Typically, cells are plated at a higher seeding density, in the presence of LIF, on a 0.1% gelatin layer in place of feeder cells.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Can KnockOut SR be used to culture mouse ESCs on feeder cells?

Yes, KnockOut SR was designed to culture mouse ES cells in undifferentiated conditions.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

How do I characterize human embryonic stem ( ES) cells?

Human ES cells are generally characterized by their typical morphology (they grow as tightly packed clusters of small cells with high ratio of nucleus to cytoplasm); surface marker expression; RT-PCR detection of stem cell-specific gene expression (such as Oct3/4, Sox2, and Nanog); alkaline phosphatase staining, and telomerase activity assay. The most commonly used ES specific surface markers include stage-specific embryonic antigens SSEA-3 and SSEA-4 for human ES cells. Other ES-specific surface antigens also include TRA-1-60 and TRA-1-81. (Science 282:1145 (1998).

How are human embryonic stem (ES) cells derived?

Human ES cells are derived from human blastocyst inner cell masses, isolated by immunosurgery with rabbit antiserum to BeWO cells (a human trophoblast cell line) (Science 282:1145 (1998)).

What are ES cells?

Embryonic stem (ES) cells are derived from the early mammalian embryo and are capable of unlimited, undifferentiated proliferation in vitro while maintaining their potential to differentiate into a wide of range of adult tissues including germ cells. The pluripotency of the ES cells is normally demonstrated in vitro by inducing ES cells to differentiate into embryoid bodies and checking lineage-specific markers for differentiated cells in three body layers (endo, meso, and ectoderm), or injecting them into immunodeficient mice and determining the cell types produced in the teratomas.

Citations & References (1)

Citations & References
Abstract
Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection.
Authors:Mier NC,Roper DK
Journal:PloS one
PubMed ID:38833479
Lentiviral vectors derived from human immunodeficiency virus type I are widely used to deliver functional gene copies to mammalian cells for research and gene therapies. Post-transcriptional splicing of lentiviral vector transgene in transduced host and transfected producer cells presents barriers to widespread application of lentiviral vector-based therapies. The present study ... More